These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18037503)

  • 1. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
    Croxford JL; Pryce G; Jackson SJ; Ledent C; Giovannoni G; Pertwee RG; Yamamura T; Baker D
    J Neuroimmunol; 2008 Jan; 193(1-2):120-9. PubMed ID: 18037503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.
    Pryce G; Baker D
    Br J Pharmacol; 2007 Feb; 150(4):519-25. PubMed ID: 17220914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.
    Hasseldam H; Johansen FF
    Neuroimmunomodulation; 2010; 17(4):252-64. PubMed ID: 20203531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.
    Ni X; Geller EB; Eppihimer MJ; Eisenstein TK; Adler MW; Tuma RF
    Mult Scler; 2004 Apr; 10(2):158-64. PubMed ID: 15124761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.
    Fernández-López D; Martínez-Orgado J; Nuñez E; Romero J; Lorenzo P; Moro MA; Lizasoain I
    Pediatr Res; 2006 Aug; 60(2):169-73. PubMed ID: 16864698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
    Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
    Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.
    Zhuang SY; Bridges D; Grigorenko E; McCloud S; Boon A; Hampson RE; Deadwyler SA
    Neuropharmacology; 2005 Jun; 48(8):1086-96. PubMed ID: 15910885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.
    Martínez-Orgado J; Fernández-Frutos B; González R; Romero E; Urigüen L; Romero J; Viveros MP
    Brain Res Mol Brain Res; 2003 Jun; 114(2):132-9. PubMed ID: 12829323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
    Ganon-Elazar E; Akirav I
    Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.